Lv1
40 积分 2024-11-23 加入
Targeting the RBM39-MEK5 axis synergizes with bortezomib to inhibit the malignant growth of multiple myeloma
2天前
已完结
Targeting the RBM39-MEK5 axis synergizes with bortezomib to inhibit the malignant growth of multiple myeloma
1个月前
已关闭
RBM39 promotes hepatocarcinogenesis by regulating RFX1’s alternative splicing and subsequent activation of integrin signaling pathway
1个月前
已完结
Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin
1个月前
已完结
Progress in the treatment of advanced gastric cancer
3个月前
已完结
miRNA-223-3p regulates ECT2 to promote proliferation, invasion, and metastasis of gastric cancer through the Wnt/β-catenin signaling pathway
3个月前
已完结
ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma
3个月前
已完结
ECT2 promotes proliferation and metastasis of esophageal squamous cell carcinoma via the RhoA-ERK signaling pathway
3个月前
已完结
ECT2 promotes malignant phenotypes through the activation of the AKT/mTOR pathway and cisplatin resistance in cervical cancer
3个月前
已完结
ECT2 promotes malignant phenotypes through the activation of the AKT/mTOR pathway and cisplatin resistance in cervical cancer
4个月前
已完结
皖公网安备34019202002308
